CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public ...

The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

When Congress adopted the Inflation Reduction Act (IRA) in 2022, creating the Medicare Drug Price Negotiation Program (MDPNP), the bill did ...

Medicare seeks public comments as the agency plans to list up to 15 additional drugs selected for the third round of pricing ...

The president has signed an executive order stating that the US will institute a “most-favored-nation” policy, whereby the US will pay the same price for a drug as the nation that pays the lowest ...

The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible ...

The third cycle of the drug price negotiations will involve drugs under Medicare Part B. New prices are set to take effect in ...

More than 100 days into President Donald Trump’s second term, the administration has fallen into a pattern. Trump releases an ...

Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...

The executive order directs Trump's administration to take actions against "discriminatory" policies in foreign countries ...

A federal appellate court has handed down the first appellate-level decision addressing the merits of drug manufacturers’ ...